From Ozempic to Mounjaro

Disclaimer: Please ensure you chat with your care provider before making any changes. They are going to support you to do it as safely as possible.  

With Ozempic in high demand and little to none to go around, and Mounjaro entering the market here in Canada, some or many of you may be considering switching from one to the other. 

Ozempic and Mounjaro are the main drugs on the market for both diabetes and obesity management. But is their dosing the same? Can you just switch without considering anything at all? (Hint: don’t do that.)

Let’s get into it. 

Related weight loss medication videos: 

▪️ Mounjaro is coming to Canada: https://youtu.be/pvIZK7pu27Q 

▪️ Ozempic Alternatives: https://youtu.be/8zsjXu8kLs4 

▪️ Muscle Loss with Ozempic, Wegovy & Mounjaro: https://youtu.be/lnEH-v64aG0 

– 

Live in Alberta? Come see me at my Pharmacist-led Obesity Clinic at Apothecare Pharmacy – http://apothecarerx.ca 

Products to support your weight loss journey: 

USA: https://amzn.to/3RC7MSd

Canada: https://amzn.to/45gq4vg

– 

Sign up for my newsletter: http://eepurl.com/gdB2qn 

– 

Have questions or need support on your weight-loss journey? Book a consultation with me: https://calendly.com/drdanconsult/he

Dr. Dan

Follow me on social media for regular updates – @TheOfficialDrDan

Subscribe to my newsletter for a heads-up on all new content.

Sharing is caring! Here’s the social, email, and even text link – https://healthevolved.co/ozempic-to-mounjaro

If you need some coaching support on your weight management journey, you can book a consultation with me to see if you’d be a good fit for our program. 

Questions or comments? Please send them my way on our Contact Us page!

Share:

More Posts

The Retatrutide Paradox: Why This “Triple Threat” Works

Retatrutide is a triple-action therapy targeting GLP-1, GIP, and glucagon receptors simultaneously — a fundamentally different design from current treatments. Early clinical data reveals significant liver-fat reductions and an unexpected paradox: a receptor long assumed to raise blood sugar instead helps mobilize stored fat and support resting metabolism.

Retatrutide TRIUMPH-1 Results: 28% Weight Loss

TRIUMPH-1 Phase 3 trial data reveals retatrutide achieved up to 30% body weight loss — outperforming bariatric surgery benchmarks without a single incision. I’m breaking down the full efficacy numbers, safety signals, and what this triple-hormone agonist means for your weight management options right now.

Slow Weight Loss on GLP-1s? This Is Why

Most people on Wegovy aren’t rapid responders — and the viral 28% weight loss headline from the STEP UP trial only tells half the story. Learn my 4-step Steady-Winner Strategy designed for the 70% who are playing the long game.

Your #1 Mistake When Taking Ozempic

Discover why the most common weight loss approach — cutting calories, carbs, and joy — is actually triggering your brain’s ancient famine alarm and working against your GLP-1 medication. I break down my counterintuitive Stack & Add Plan: five steps that work with your biology to protect muscle, outsmart metabolic adaptation, and finally walk through the door your medication opened.

Send Us A Message

Try My New Calorie Calculator!

Calculate your daily calorie and protein targets to help you achieve your weight goals.

Try My New Calorie Calculator!

Calculate your daily calorie and protein targets to help you achieve your weight goals.